The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

Use of PubMed’s conflict-of-interest field has increased over time, but utilization remains limited, according to research ...

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

A study of pediatric skiing-related injuries showed rates of sprains and contusions decreased, while rates of fractures and ...

Nearly 70% of adolescents report having at least one social media account, including 63.8% of youth aged younger than 13 ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...

Published results showed patients with chronic inflammatory diseases, such as rheumatoid arthritis and lupus, may have ...

President Donald J. Trump signed an executive order withdrawing the United States from WHO, mostly due to the belief that the ...

A higher cefazolin dose was not associated with decreased rates of surgical site infections among obese patients undergoing ...

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

Patients who receive kidney transplants from Epstein–Barr virus D-positive/R-negative donors face a higher risk of ...

The FDA expanded the approval of trastuzumab deruxtecan for treatment of breast cancer.The new indication applies to use of ...